- Home
- BIDU vs WAT Comparison
BIDU vs WAT Comparison
Compare BIDU & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIDU | WAT |
|---|---|---|
| Founded | 2000 | 1958 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 33.5B |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BIDU | WAT |
|---|---|---|
| Price | $90.55 | $417.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | $154.38 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 3.3M | 591.4K |
| Earning Date | 05-18-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.11 | $104.66 |
| Revenue Next Year | $7.44 | $10.40 |
| P/E Ratio | $42.45 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $89.60 | $282.77 |
| 52 Week High | $165.30 | $426.22 |
Technical Indicators
Market Signals| Indicator | BIDU | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 36.67 | 51.37 |
| Support Level | $89.60 | $372.33 |
| Resistance Level | $99.64 | $426.22 |
| Average True Range (ATR) | 1.83 | 10.34 |
| MACD | 0.09 | -2.07 |
| Stochastic Oscillator | 10.69 | 40.35 |
Price Performance
Historical ComparisonAbout BIDU Baidu Inc. ADS
Most of Baidu's revenue comes from Baidu core, with the rest coming from video-streaming subsidiary iQiyi. The firm's main businesses include online marketing services from its search engine, AI cloud infrastructure, AI applications, AI marketing, and autonomous driving.
About WAT Waters Corporation
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.